Toggle navigation
ABOUT US
Overview
Leadership
Governance
Board
Our purpose
Global footprint
Our global reach
Partners
Press releases
News
Our science
Drug optimization
Lauriad
®
technology
Overview
How it works
Scientific publications
Lauriad
®
applications
OUR MEDICINES
PIPELINE
Commercialized medicines
Sitavig
®
Loramyc
®
PARTNER WITH US
Commercial & Industrial partners
Academic & Research collaborations
Careers
Working at Vectans Pharma
Join us
CONTACT
Nomination of François Boutignon as Chief Innovation and Technology Officer
Read the press release
Last news
Vectans Pharma participated in a symposium about new treatments in Oropharyngeal Candidiasis
CPhI Worldwide 2022 in Frankfurt, November 1
st
-3
rd
Exclusif agreement with Berlin Chemie for Sitavig
®
Welcome to Medine Kockan, our new talent!
Navamedic ASA : exclusive agreement for Sitavig
®
230 Bureaux de la colline
92213 Saint-Cloud
France
contact@vectans.com
FOLLOW US
Copyright © VECTANS PHARMA
Legal notices and privacy policy
